30
Views
6
CrossRef citations to date
0
Altmetric
Original Article

A case of isoniazid-induced optic neuropathy

&
Pages 67-70 | Accepted 09 Apr 1981, Published online: 08 Jul 2009

References

  • Ahmad I., Clark L. A. lsoniazid hypersensitivity reaction involving the eyes. Report of a case. Dis. Chest 1967; 52: 112
  • Albengres E., Houin G., Breau J.-L., Hirsch A., Saltiel J. c., Tillement J.-P., Chretien J. Modification, en cours de traitement, de la vitesse d'acétylation de I'isoniazide sans atteinte hèkpatique décelable. Now. Presse méd. 1977; 6–32: 2869
  • Biehl J. P., Vilter R. W. Effect of isoniazid on pyridoxine metabolism. J. Amer. med. Ass. 1954; 156: 1549
  • Clavel A. Retrobulbar optic neuritis during treatment with isoniazid. Bull. Soc. Ophtal. Etude France 1961; 9–10: 786–787
  • Dixon G. J., Roberts G. B. S, Tyrrell W. F. The relationship of neuropathy to the treatment of tuberculosis with isoniazid. Scot. med. J. 1956; 1: 350
  • Gronhagen-Riska C., Hellstrom P. E., Froseth B. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis. Amer. Rev. resp. Dis. 1978; 118: 461
  • Hughes H. B. On the metabolic fate of isoniazid. J Pharmacol, exp. Ther. 1953; 109: 444
  • Hughes R. A. C, Mair W. G. P. Acute necrotic myelopathy with pulmonary tuberculosis. Brain 1977; 100: 233
  • Kass I., Mandel W., Cohen H., Dressler S. H. isoniazid as a cause of optic neuritis and atrophy. J. Amer. med. Ass. 1957; 164: 1740
  • Keeping J. A. Optic neuritis following isoniazid therapy. Lancer 1955; 278
  • Lesobre R., Ruffino J., Teyssier L., Archard Brefort G. Les icttres au cours du traitement par le rifampicine. Rev. Tuba. 1969; 33: 393
  • Renard G., Morax P. V. Névrite optique au cours des traitements antituberculeux. Ann. Oculist. (Paris) 1977; 21053
  • Sutton P. H., Beattie P. H. Optic atrophy after administration of isoniazid with P.A.S. Lancet 1955; I(650)
  • Suzuki T., in preparation

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.